OIG: Drugmakers should disclose wholesale prices to CMS

04/27/2011 | Hill, The

Medicare could save $4.4 million each year by reducing reimbursement for drugs covered under Part B that have an average sale price at least 5% more than the wholesale price, according to an HHS Inspector General's report. The CMS responded by saying doing so would violate a court order against disclosing wholesale prices to the public.

View Full Article in:

Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC